[
  {
    "ts": "2026-02-14T13:35:00+00:00",
    "headline": "2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off",
    "summary": "These two stocks have historically zigged when the market has zagged.",
    "url": "https://www.fool.com/investing/2026/02/14/unstoppable-dividend-stocks-buy-if-sell-off/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "03cb7aa4-ec33-3a48-bf0c-45b233cf07ea",
      "content": {
        "id": "03cb7aa4-ec33-3a48-bf0c-45b233cf07ea",
        "contentType": "STORY",
        "title": "2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off",
        "description": "",
        "summary": "These two stocks have historically zigged when the market has zagged.",
        "pubDate": "2026-02-14T13:35:00Z",
        "displayTime": "2026-02-14T13:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/5781c9e3b2339509043cc5ca81b6e81f",
          "originalWidth": 1400,
          "originalHeight": 787,
          "caption": "Person at desk in dark office, looking at charts on screens.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M8pETPR60Mkfb2e9ZZ1Zlw--~B/aD03ODc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/5781c9e3b2339509043cc5ca81b6e81f.cf.webp",
              "width": 1400,
              "height": 787,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qvVcImgP.9uUSbVK7t1HRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/5781c9e3b2339509043cc5ca81b6e81f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/14/unstoppable-dividend-stocks-buy-if-sell-off/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-unstoppable-dividend-stocks-buy-133500211.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-14T23:11:37+00:00",
    "headline": "AbbVie’s Botox Lawsuit Puts Medicare Pricing Risks In Focus",
    "summary": "AbbVie (NYSE:ABBV) has filed a lawsuit against the U.S. Department of Health and Human Services over the inclusion of Botox in Medicare price negotiations. The company argues that Botox should be exempt under current federal legislation governing Medicare pricing. The legal challenge adds to a broader wave of industry pushback against U.S. government drug pricing policies. AbbVie is a large biopharmaceutical company with a portfolio that spans immunology, oncology, neuroscience, and...",
    "url": "https://finance.yahoo.com/news/abbvie-botox-lawsuit-puts-medicare-231137265.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7b153959-5943-3c4e-bd35-7b440c9e594b",
      "content": {
        "id": "7b153959-5943-3c4e-bd35-7b440c9e594b",
        "contentType": "STORY",
        "title": "AbbVie’s Botox Lawsuit Puts Medicare Pricing Risks In Focus",
        "description": "",
        "summary": "AbbVie (NYSE:ABBV) has filed a lawsuit against the U.S. Department of Health and Human Services over the inclusion of Botox in Medicare price negotiations. The company argues that Botox should be exempt under current federal legislation governing Medicare pricing. The legal challenge adds to a broader wave of industry pushback against U.S. government drug pricing policies. AbbVie is a large biopharmaceutical company with a portfolio that spans immunology, oncology, neuroscience, and...",
        "pubDate": "2026-02-14T23:11:37Z",
        "displayTime": "2026-02-14T23:11:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-botox-lawsuit-puts-medicare-231137265.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-botox-lawsuit-puts-medicare-231137265.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]